EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Therapeutic Potential of Dihydroartemisinin in Cancer Treatment

Zhaochuan Hu, Shuai Zhang, Yongqi Shi, Yunlei Song, Dan Miao, Wenhe Xiong, Jiaying Guo, Yumao Jiang

International Journal of Molecular Sciences · 10.04.2026 · 27 (8) · 3420

DOI: 10.3390/ijms27083420 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.04.2026. Verfasst von Zhaochuan Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ministry of Education, Jiangxi Provincial Key Laboratory of Tissue Engineering, Key Laboratory of Prevention and Treatment of Cardiovascular and Cere…. Hauptthemen laut MEDLINE: Artemisinins, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key R&D Project of Ganzhou Science and Technology Plan Project, Science and Technology Research Project of Jiangxi Provincial Department of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dihydroartemisinin (DHA), the active metabolite of artemisinin derivatives, is a clinically established antimalarial agent that has recently gained significant attention for its anticancer properties. This review systematically examines the molecular mechanisms underlying DHA’s antitumor effects and explores innovative strategies to enhance its bioavailability and therapeutic efficacy. DHA demonstrates substantial potential in combination therapies with conventional clinical agents, with its broad anticancer applications being strongly supported by both preclinical and clinical evidence. Furthermore, this article outlines future research directions, discusses challenges in clinical translation, and summarizes current scientific approaches addressing these limitations. Collectively, this review highlights DHA’s promising role in cancer treatment and provides a foundation for developing improved therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArtemisininsNeoplasmsAntineoplastic AgentsHumansAnimalsAntimalarials

Stichwörter der Autor:innen

cancer therapycombination therapydihydroartemisinindrug delivery systemshybrid compounds

Substanzen

ArtemisininsartenimolAntineoplastic AgentsAntimalarials

Autor:innen und Institutionen

  • Ministry of Education, Jiangxi Provincial Key Laboratory of Tissue Engineering, Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, Scientific Research Center, Gannan Medical Unive…

Förderung

  • National Natural Science Foundation of China
  • Key R&D Project of Ganzhou Science and Technology Plan Project
  • Science and Technology Research Project of Jiangxi Provincial Department of Education
  • Key R&D Project of Ganzhou Science and Technology Plan Project

Zitieren

APA

Hu, Z., Zhang, S., Shi, Y., Song, Y., Miao, D., Xiong, W., Guo, J., & Jiang, Y. (2026). The Therapeutic Potential of Dihydroartemisinin in Cancer Treatment. International Journal of Molecular Sciences, 27(8), 3420. https://doi.org/10.3390/ijms27083420

Vancouver

Hu Z, Zhang S, Shi Y, Song Y, Miao D, Xiong W, et al. The Therapeutic Potential of Dihydroartemisinin in Cancer Treatment. International Journal of Molecular Sciences. 2026;27(8):3420. doi:10.3390/ijms27083420

BibTeX
@article{Hu2026,
  author = {Hu, Zhaochuan and Zhang, Shuai and Shi, Yongqi and Song, Yunlei and Miao, Dan and Xiong, Wenhe and Guo, Jiaying and Jiang, Yumao},
  title = {The Therapeutic Potential of Dihydroartemisinin in Cancer Treatment},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {8},
  pages = {3420},
  doi = {10.3390/ijms27083420}
}
Kostenlos starten →